NEW YORK, Aug. 30 – Bruker Daltonics and Thermo Finnigan have reached a settlement agreement in their multi-year, international patent dispute over the companies’ ion trap mass spectrometry technologies, the companies announced Thursday.

As part of the agreement, both companies have agreed to dismiss all pending suits throughout the US and Europe and waive all damages related to the disputes. The agreement also provides a framework of licensing and arbitration for potential future patent disagreements between the companies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.